Rice endosperm produces an underglycosylated and potent form of the HIV-neutralizing monoclonal antibody 2G12
Twyman, Richard M.
Melro Murad, Andre
Yi-Hui Teh, Audrey
Ma, Julian K-C.
MetadataShow full item record
Protein microbicides against HIV can help to prevent infection but they are required in large, repetitive doses. This makes current fermenter-based production systems prohibitively expensive. Plants are advantageous as production platforms because they offer a safe, economical and scalable alternative,
and cereals such as rice are particularly attractive because they could allow pharmaceutical proteins to be produced economically and on a large scale in developing countries. Pharmaceutical proteins can also be stored as unprocessed seed, circumventing the need for a cold chain. Here, we report the development of transgenic rice plants expressing the HIV-neutralizing antibody 2G12 in the endosperm. Surprisingly for an antibody expressed in plants, the heavy chain was predominantly aglycosylated. Nevertheless, the heavy and light chains assembled into functional antibodies with more potent HIV-neutralizing activity than other plant-derived forms of 2G12 bearing typical high-mannose or plant complex-type glycans. Immunolocalization experiments showed that the assembled antibody accumulated predominantly in protein storage vacuoles but also induced the formation of novel, spherical storage compartments surrounded by ribosomes indicating that they originated from the endoplasmic reticulum. The comparison of wild-type and transgenic plants at the transcriptomic and proteomic levels indicated that endogenous genes related to starch biosynthesis were down-regulated in the endosperm of the transgenic plants, whereas genes encoding prolamin and glutaredoxin-C8 were up-regulated. Our data provide insight into factors that affect the functional efficacy of neutralizing antibodies in plants and the impact of recombinant proteins on endogenous gene expression.
Is part ofPlant Biotechnology Journal, 2016, vol. 14, núm. 1, p. 97-108
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as cc-by (c) Society for Experimental Biology, Association of Applied Biologists and John Wiley & Sons Ltd, 2015
Showing items related by title, author, creator and subject.
Vamvaka, Evangelia; Farré Martinez, Gemma; Molinos-Albert, Luis M.; Evans, Abbey; Canela Xandri, Anna; Twyman, Richard M.; Carrillo, Jorge; Ordóñez, Raziel Antonio; Shattock, Robin J.; O’Keef, Barry R.; Clotet, Bonaventura; Blanco, Julian; Khush, Gurdev S.; Christou, Paul; Capell Capell, Teresa (National Academy of Sciences, 2018-08-14)The transmission of HIV can be prevented by the application of neutralizing monoclonal antibodies and lectins. Traditional recombinant protein manufacturing platforms lack sufficient capacity and are too expensive for ...
Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants Ma, Julian K-C.; Drossard, Jürgen; Lewis, David; Altmann, Friedrich; Boyle, Julia; Christou, Paul; Cole, Tom; Dale, Philip; van Dolleweerd, Craig J.; Isitt, Valerie; Katinger, Dietmar; Lobedan, Martin; Mertens, Hubert; Paul, Mathew; Rademacher, Thomas; Sack, Markus; Hundleby, Penelope A. C.; Stiegler, Gabriela; Stöger, Eva; Twyman, Richard M.; Vcelar, Brigitta; Fischer, Rainer (Wiley, 2015)Although plant biotechnology has been widely investigated for the production of clinical-grade monoclonal antibodies, no antibody products derived from transgenic plants have yet been approved by pharmaceutical regulators ...
Cyanovirin-N produced in rice endosperm offers effective pre-exposure prophylaxis against HIV-1BaL infection in vitro Vamvaka, Evangelia; Evans, Abbey; Ramessar, Koreen; Krumpe, L. R. H.; Shattock, Robin J.; O’Keefe, Barry R.; Christou, Paul; Capell Capell, Teresa (Springer Berlin Heidelberg, 2016)Cyanovirin-N (CV-N) is a lectin with potent antiviral activity that has been proposed as a component of microbicides for the prevention of infection with Human immunodeficiency virus (HIV). The production of protein-based ...